Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6239
Source ID: NCT00618007
Associated Drug: Pf-00734200 30 Mg Qd
Title: Effect of PF-00734200 in Subjects With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: PF-00734200 30 mg QD|DRUG: PF-00734200 20 mg QD|DRUG: Placebo
Outcome Measures: Primary: HbA1c, 12 weeks | Secondary: Fasting Glucose, 12 weeks|Fasting Insulin, 12 weeks
Sponsor/Collaborators: Sponsor: Pfizer
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 289
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2008-02
Completion Date: 2008-08
Results First Posted:
Last Update Posted: 2011-06-27
Locations: Pfizer Investigational Site, Birmingham, Alabama, 35205, United States|Pfizer Investigational Site, Chandler, Arizona, 85225, United States|Pfizer Investigational Site, Litchfield Park, Arizona, 85340, United States|Pfizer Investigational Site, Phoenix, Arizona, 85051, United States|Pfizer Investigational Site, Artesia, California, 90701, United States|Pfizer Investigational Site, Cerritos, California, 90703, United States|Pfizer Investigational Site, Fresno, California, 93720, United States|Pfizer Investigational Site, Greenbrea, California, 94904, United States|Pfizer Investigational Site, Huntington Beach, California, 92648, United States|Pfizer Investigational Site, Los Angeles, California, 90057, United States|Pfizer Investigational Site, National City, California, 91950, United States|Pfizer Investigational Site, Roseville, California, 95661, United States|Pfizer Investigational Site, Valley Village, California, 91607, United States|Pfizer Investigational Site, West Covina, California, 91790, United States|Pfizer Investigational Site, DeFuniak Springs, Florida, 32435, United States|Pfizer Investigational Site, Jacksonville, Florida, 32205, United States|Pfizer Investigational Site, Miami, Florida, 33143, United States|Pfizer Investigational Site, Miami, Florida, 33169, United States|Pfizer Investigational Site, New Port Richey, Florida, 34652, United States|Pfizer Investigational Site, Ocala, Florida, 34471, United States|Pfizer Investigational Site, Pinecrest, Florida, 33156, United States|Pfizer Investigational Site, St. Petersburg, Florida, 33702, United States|Pfizer Investigational Site, Conyers, Georgia, 30094, United States|Pfizer Investigational Site, Idaho Falls, Idaho, 83404, United States|Pfizer Investigational Site, Indianapolis, Indiana, 46260, United States|Pfizer Investigational Site, Wichita, Kansas, 67203, United States|Pfizer Investigational Site, Lexington, Kentucky, 40504, United States|Pfizer Investigational Site, Madisonville, Kentucky, 42431, United States|Pfizer Investigational Site, Scarborough, Maine, 04074, United States|Pfizer Investigational Site, Baltimore, Maryland, 21204, United States|Pfizer Investigational Site, Oxon Hill, Maryland, 20745, United States|Pfizer Investigational Site, Ann Arbor, Michigan, 48106, United States|Pfizer Investigational Site, Bay City, Michigan, 48706, United States|Pfizer Investigational Site, Canton, Michigan, 48187, United States|Pfizer Investigational Site, Troy, Michigan, 48098, United States|Pfizer Investigational Site, Jackson, Mississippi, 39209, United States|Pfizer Investigational Site, Picayune, Mississippi, 39466, United States|Pfizer Investigational Site, St. Louis, Missouri, 63117, United States|Pfizer Investigational Site, St. Louis, Missouri, 63141, United States|Pfizer Investigational Site, St. Peters, Missouri, 63376, United States|Pfizer Investigational Site, Las Vegas, Nevada, 89128, United States|Pfizer Investigational Site, Elizabeth, New Jersey, 07202, United States|Pfizer Investigational Site, Trenton, New Jersey, 08611, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87106, United States|Pfizer Investigational Site, Syracuse, New York, 13210, United States|Pfizer Investigational Site, Winston-Salem, North Carolina, 27103, United States|Pfizer Investigational Site, Marion, Ohio, 43302, United States|Pfizer Investigational Site, Eugene, Oregon, 97401, United States|Pfizer Investigational Site, Cumberland, Rhode Island, 02864, United States|Pfizer Investigational Site, Aiken, South Carolina, 29801, United States|Pfizer Investigational Site, Florence, South Carolina, 29501, United States|Pfizer Investigational Site, Kingsport, Tennessee, 37660, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, Dallas, Texas, 75235, United States|Pfizer Investigational Site, El Paso, Texas, 79935, United States|Pfizer Investigational Site, Houston, Texas, 77023, United States|Pfizer Investigational Site, Houston, Texas, 77081, United States|Pfizer Investigational Site, Hurst, Texas, 76054, United States|Pfizer Investigational Site, Odessa, Texas, 79761, United States|Pfizer Investigational Site, Pearland, Texas, 77584, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States|Pfizer Investigational Site, Salt Lake City, Utah, 84107, United States|Pfizer Investigational Site, Bennington, Vermont, 05201-5018, United States|Pfizer Investigational Site, Ettrick, Virginia, 23803, United States|Pfizer Investigational Site, Richmond, Virginia, 23225, United States|Pfizer Investigational Site, Virginia Beach, Virginia, 23454, United States|Pfizer Investigational Site, Virginia Beach, Virginia, 23455, United States|Pfizer Investigational Site, Spokane, Washington, 99208, United States|Pfizer Investigational Site, Kenosha, Wisconsin, 53142, United States|Pfizer Investigational Site, Coquitlam, British Columbia, V3K 3P4, Canada|Pfizer Investigational Site, Toronto, Ontario, M9W 4L6, Canada|Pfizer Investigational Site, Laval, Quebec, H7T 2P5, Canada|Pfizer Investigational Site, Pointe-Claire, Quebec, H9R 4S3, Canada|Pfizer Investigational Site, Quebec, G1V 4M6, Canada|Pfizer Investigational Site, Seoul, 110-744, Korea, Republic of|Pfizer Investigational Site, Seoul, 120-752, Korea, Republic of|Pfizer Investigational Site, Seoul, 135-710, Korea, Republic of|Pfizer Investigational Site, Seoul, 136-705, Korea, Republic of|Pfizer Investigational Site, San Juan, 00909-1711, Puerto Rico
URL: https://clinicaltrials.gov/show/NCT00618007

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress